KKR has agreed to acquire a 20% stake in Singtel’s Asia data centre business for SGD 1.1bn (USD 800m) via its infrastructure strategy.
Kedaara Capital has acquired a significant minority stake in India-based education technology business K12 Techno Services, facilitating a partial exit for Peak XV Partners (formerly Sequoia Capital India).
Lion X Ventures and Vickers Venture Partners have led a Series B round of approximately USD 20m for Awak Technologies, a Singaporean start-up that makes wearable dialysis treatment devices.
BlueRun Ventures China has been rebranded as Lanchi Ventures to differentiate itself from the Silicon Valley-headquartered VC firm with which it shares a name.
Some LPs have increased their return expectations for Chinese private equity, and they are calling on local managers to be more disciplined on entry valuations and more tenacious on exits in the hope that these higher thresholds can be met.
Investors targeting green technology in China are looking beyond saturated areas such as renewable energy projects to opportunities that target unaddressed industry pain points, the AVCJ Private Equity & Venture Forum China 2023 heard.
MDI Ventures, an investment firm supported by Telkom Indonesia, has merged two existing programmes to form Ascent Venture Group, which is looking to raise USD 200m for deployment in Southeast Asia.
Singapore-based e-commerce services provider Amp, which was founded by the team behind inventory and order management platform TradeGecko, has raised USD 18.5m in Series A funding.
Sumitomo Life will become the largest shareholder in Singapore Life (Singlife) – an insurer also backed by TPG Capital – having agreed to acquire Aviva’s 25.9% stake in the business for GBP 800m (USD 999m).
Global expansion remains a bright spot in China’s investment landscape as private equity firms slow deployment domestically in favour of supporting China-related entrepreneurs or business concepts in other markets, the AVCJ Private Equity & Venture...
Vertex Ventures Southeast Asia and India (VVSEAI), an early-stage investor affiliated with Temasek Holdings-owned Vertex Holdings, has closed its fifth fund with USD 541m in commitments.
C Capital, an investment firm established by Adrian Cheng, scion of Hong Kong’s New World Development, has closed its latest private equity fund with around USD 250m in commitments.
By investing early and building a diversified portfolio, 500 Global emerged from the technology valuation corrections somewhat unscathed. This gave the firm impetus when raising its third Southeast Asia fund
ShawKwei & Partners found its niche in Asia-based industrials businesses with relative cost advantages. Thanks to geopolitics and shifting growth patterns, the GP is now targeting assets in North America
Educational Initiatives was not part of India’s pandemic-driven ed-tech explosion. The PE-owned company emerged from the chaos having reaffirmed its sustainable, school-facing business model
Private equity has become comfortable with niche segments and regional sub-markets in Indian healthcare services. Technology-based business models are next
China’s consumer sector is poised for one of its most lucrative vintages with investors able to take advantage of falling valuations, the AVCJ Private Equity & Venture Forum China 2023 heard.
Protégé Ventures (PV), a student-run venture fund programme set up by the Singapore Management University Institute of Innovation & Entrepreneurship (SMU IIE) has launched a second fund of SGD 500,000 (USD 367,000).
L Catterton’s interest in Asian pet food and services has stretched from China to India and now Japan with a commitment of undisclosed size to Withmal, a Japanese veterinary services group.
KKR has agreed to re-up in India’s Reliance Retail, committing another INR 20.6bn (USD 250m) on top of the INR 55bn it put into the neighbourhood store-to-supermarket operator three years ago.
Investors in Chinese healthcare are looking for innovators with global competencies to lead an industry recovery following a challenging past 12 months, the AVCJ Private Equity & Venture Forum China 2023 heard.
CICC Capital had led a USD 60m Series B round for Grit Biotechnology, a Shanghai-based drug developer that is working on pioneering cancer treatments involving tumour-infiltrating lymphocytes (LIT).
IFM Investors has committed approximately NZD 50m (USD 29m) to New Zealand-based energy sector software provider Tally Group alongside existing investors SilverTree Equity and Pioneer Capital.